MarketPeel
Pricing
…
EVP, General Counsel
James Basta
Tue, Mar 1, 2022
Mar 1
received an award in NTLA
9,648 shares @ $0.00
Increased holdings by +87.30%
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+8.28%
1M+17.05%
3M-6.55%
6M—
1Y—

Recent insider activity at NTLA

Aug 21John M. LeonardSold$36.20kAug 20John M. LeonardSold$250.61kJul 22Edward J. III DulacSold$91.25kJul 2Edward J. III DulacSold$84.19kJul 1Michael P. DubeSold$44.32kMar 2James BastaSold$16.69kMar 2Eliana ClarkSold$8.36kJan 5James BastaSold$95.76k
Full NTLA profile →James Basta’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback